| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $201K | -59.1% | -80.6% |
| Cost of Revenue | $0 | — | — |
| R&D Expense | $2.9M | +85.2% | -28.9% |
| SG&A Expense | $4.3M | +74.0% | +51.5% |
| Operating Income | -$7.0M | -97.3% | -18.6% |
| Pre-tax Income | -$6.0M | -32.9% | +22.3% |
| Income Tax | $0 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $6.8M | -27.5% | -51.0% |
| Accounts Receivable | $266K | -67.4% | -66.2% |
| Current Assets | $8.3M | -30.0% | -67.1% |
| Total Assets | $11.6M | -24.1% | -60.1% |
| Current Liabilities | $2.8M | -9.1% | -50.5% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$16.0M | — | — |
| Capital Expenditures | $9K | — | — |
| Investing Cash Flow | -$9K | — | — |
| Financing Cash Flow | $2.8M | — | — |
| Free Cash Flow | -$16.0M | — | — |
| — |
| Net Income | -$6.0M | -32.9% | +22.3% |
| EPS (Basic) | -$1.14 | -1800.0% | -1040.0% |
| EPS (Diluted) | -$1.14 | -1800.0% | -1040.0% |
| $65.6M |
| +2.4% |
| +2.6% |
| Stockholders' Equity | -$54.0M | -10.7% | -55.1% |